Bioshastra.in

Making Drugs

Branded vs. Generic Drugs

Generic medicines are therapeutically equivalent alternatives to brand-name drugs, offering the same clinical outcomes at a fraction of the cost.

A generic drug is created to be the same as an already approved brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. At Bioshastra, we focus on lowering patient costs by developing high-fidelity generic bio-equivalents that maintain absolute therapeutic success.

Key Equivalence Metrics:

Active Ingredients: Identical chemical structure and pharmacological action.
Bio-equivalence: Identical rate and extent of drug absorption in the body.
Quality Testing: Subject to the same strict FDA and WHO GMP guidelines as branded equivalents.

Making Drugs

Biologics & Biosimilars

Unlike chemical drugs, biologics are complex molecules manufactured inside living cells, demanding state-of-the-art bio-reactor technology.

Biosimilars are highly similar versions of reference biologic drugs. While biological synthesis naturally exhibits minor variations due to living systems, biosimilars show no clinically meaningful differences in safety, purity, or potency. Bioshastra leverages cutting-edge bioinformatics to model cellular folding patterns, ensuring that our biosimilars deliver identical therapeutic responses.

Our Biotech Edge:

Living Bio-Reactors: Highly optimized cell lines for protein and antibody expression.
Structural Mapping: Verify molecular folding using sub-angstrom computational mapping.
Equivalent Potency: In-vitro assays validating equal molecular target engagement.

Biologics and Biosimilars reactor synthesis

Supply & Logistics

Global Supply Chain

Getting therapies to patients requires global logistical speed coupled with cold-chain security.

Bioshastra operates a robust, multi-continent logistical network. We manage sterile, temperature-controlled cold chains monitored by IoT sensors in real-time. This guarantees that delicate biological molecules and APIs are delivered in perfect therapeutic condition, from local shipping ports to patient dispensaries.

Supply Chain Metrics:

Real-Time IoT Tracking: GPS and thermal monitors ensuring cold-chain integrity.
Redundant Warehousing: Strategic reserves in key regional depots to prevent shortages.
Secure Distribution: Certified distributor partnerships with audited safe handling.

Global supply chain smart cold transit container

Infrastructure

Advanced Manufacturing Sites

Our state-of-the-art facilities run automated molecular packaging and cleanroom operations.

Our manufacturing centers are certified by leading global agencies (US-FDA, WHO-GMP). We use sterile cleanroom enclosures equipped with positive-pressure HEPA filters to avoid any micro-contamination. Automated packaging robotics ensure safety sealing, label accuracy, and rapid product dispatch.

Facility Standards:

Class 100 Cleanrooms: Maximum safety for biopharmaceutical bottling.
Robotic Packaging: Human-free packaging environments to prevent microbial hazards.
Eco-Friendly Operations: Zero liquid discharge systems recycling 98% of facility water.

Advanced Cleanroom packaging robotic line

Drugs in Making & Safety